Concomitant use of a RAF inhibitor, RAF265, and a dual PI3K/mTOR inhibitor, BEZ-235, was another effective combinatorial therapy against thyroid cancer in xenograft mouse models [102]. The gene discussed is MTOR; the disease is thyroid gland carcinoma.